NASDAQ: OMDAOmada Health Inc Stock
$17.33+0.19 (+1.11%)
Updated Jun 15, 2026
OMDA Price
$17.33
Fair Value Price
N/A
Market Cap
$1.03B
52 Week Low
$10.28
52 Week High
$26.92
P/E
-192.56x
P/B
4.4x
P/S
2.61x
PEG
N/A
Dividend Yield
N/A
Revenue
$283.30M
Earnings
-$6.30M
Gross Margin
66.3%
Operating Margin
-1.7%
Profit Margin
-2.2%
Debt to Equity
0.29
Operating Cash Flow
$23M
Beta
1.21
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
OMDA Overview
Omada Health is an American virtual health company that delivers evidence-based digital programs designed to manage common chronic ailments, including cardiometabolic, musculoskeletal, and behavioral health conditions, offering continuous support that bridges the gap between in-person medical appointments.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine OMDA's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Health Information Service
Industry Rating
C
OMDA
Ranked#13 of 45
Ranked#13 of 45
Be the first to know about important OMDA news, forecast changes, insider trades & much more!
OMDA News
Overview
Due Diligence Score
–
Industry Average (31)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how OMDA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
OMDA is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
OMDA is poor value based on its book value relative to its share price (4.4x), compared to the US Health Information Services industry average (3.11x)
P/B vs Industry Valuation
OMDA is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more OMDA due diligence checks available for Premium users.
Valuation
OMDA fair value
Fair Value of OMDA stock based on Discounted Cash Flow (DCF)
Price
$17.33
Fair Value
-$11.26
Undervalued by
253.91%
OMDA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
OMDA price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-192.56x
Industry
14.16x
Market
14.3x
OMDA price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
4.4x
Industry
3.11x
OMDA is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
OMDA's financial health
Profit margin
Revenue
$78.0M
Net Income
-$3.0M
Profit Margin
-3.8%
OMDA's Earnings (EBIT) of -$4.82M... subscribe to Premium to read more.
Interest Coverage Financials
OMDA's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$302.8M
Liabilities
$68.7M
Debt to equity
0.29
OMDA's short-term assets ($269.43M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
OMDA's short-term assets ($269.43M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
OMDA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$11.8M
Investing
-$1.6M
Financing
$3.1M
OMDA's operating cash flow ($22.54M)... subscribe to Premium to read more.
Debt Coverage Financials
OMDA vs Health Information Service Stocks
Omada Health Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.